Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
Carl Icahn's Portfolio
|Company||Ticker||# of Shares||Change||Price||Value|
|CVR Energy||CVI||71,198,718||$67.90||$4,834,392,953||History »||Related Stories »|
|Chesapeake Energy Corp.||CHK||59,698,689||$21.67||$1,293,670,591||History »||Related Stories »|
|NetFlix, Inc.||NFLX||5,541,066||$228.74||$1,267,463,437||History »||Related Stories »|
|Forest Laboratories, Inc.||FRX||30,662,005||$39.23||$1,202,870,457||History »||Related Stories »|
|Transocean||RIG||20,154,035||+14,315,649||$52.06||$1,049,219,063||History »||Related Stories »|
|Herbalife||HLF||16,966,485||+16,966,485||$47.65||$808,453,011||History »||Related Stories »|
|Federal-Mogul Corporation||FDML||76,697,804||$9.42||$722,493,314||History »||Related Stories »|
|Nuance Communications, Inc.||NUAN||33,899,274||+33,899,274||$19.21||$651,205,054||History »||Related Stories »|
|Hain Celestial Group, Inc.||HAIN||7,239,963||$68.44||$495,503,068||History »||Related Stories »|
|Navistar International||NAV||11,845,167||$35.88||$425,004,592||History »||Related Stories »|
|ICAHN ENT DEP UTS||IEP||5,329,130||+959,068||$76.25||$406,346,163||History »||Related Stories »|
|Mentor Graphics Corp||MENT||16,120,289||$18.46||$297,580,535||History »||Related Stories »|
|FreightCar America, Inc.||RAIL||11,871,268||$17.64||$209,409,168||History »||Related Stories »|
|Take-Two Interactive Softwar||TTWO||12,020,744||$16.02||$192,572,319||History »||Related Stories »|
|WebMD Health Corp.||WBMD||6,700,525||$28.57||$191,434,000||History »||Related Stories »|
|CVR Refining LP||CVRR||4,000,000||+4,000,000||$30.36||$121,440,000||History »||Related Stories »|
|Dell, Inc.||DELL||7,000,000||+7,000,000||$13.34||$93,380,000||History »||Related Stories »|
|Enzon Pharmaceuticals, Inc.||ENZN||5,904,863||$3.16||$18,659,368||History »||Related Stories »|
|MOTRICITY, Inc.||MOTR||6,782,039||$0.36||$2,441,535||History »||Related Stories »|